Zinc May Shorten Duration of Common Cold in Adults

Symptoms reduced in adults, but not children; bad taste, nausea are common adverse effects

MONDAY, May 7 (HealthDay News) -- Oral zinc may shorten the duration of symptoms associated with the common cold in adults, but adverse effects are common, according to a review published online May 7 in CMAJ, the journal of the Canadian Medical Association.

Michelle Science, M.D., from the Hospital for Sick Children in Toronto, and colleagues conducted a systematic literature review and meta-analysis. Randomized controlled trials comparing orally administered zinc with placebo or no treatment were included.

The researchers found 17 trials that included a total of 2,121 participants. Participants receiving zinc had a shorter duration of cold symptoms than those receiving placebo (mean difference, −1.65 days; 95 percent confidence interval [CI], −2.50 to −0.81). Zinc shortened the duration of cold symptoms in adults (mean difference, −2.63 days; 95 percent CI, −3.69 to −1.58) but had no significant effect in children (mean difference, −0.26 days; 95 percent CI, −0.78 to 0.25). Heterogeneity was high in all subgroup analyses. Compared to the placebo group, the risk ratio (RR) for any adverse event for those in the zinc group was 1.24 (95 percent CI, 1.05 to 1.46), and included bad taste (RR, 1.65; 95 percent CI, 1.27 to 2.16) and nausea (RR, 1.64; 95 percent CI, 1.19 to 2.27).

"The results of our meta-analysis showed that oral zinc formulations may shorten the duration of symptoms of the common cold," the authors write.

All studies included in the review were funded by the pharmaceutical industry.

Abstract
Full Text

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events